• Pharmacotherapy review reduces costs and minimizes risks present by polypharmacy
    Permalink Gallery

    Potential Workers Compensation Cost Drivers- Private Label Topicals

Potential Workers Compensation Cost Drivers- Private Label Topicals

We are seeing a trend in which doctors are increasingly prescribing private label topical drugs for the treatment of chronic pain. Awareness of these expensive and clinically unproven products is becoming increasingly important due to their potential safety and cost implications.

What are they?

Differing from custom compounds, private label topicals are similar to over-the-counter (OTC) topical products, with varying formulations that are not clinically tested for either safety or efficacy. Private-label topical analgesics are not recommended according to evidence-based guidelines and they are not approved by the FDA.

From a clinical perspective, private-label […]

By |February 29th, 2016|Pharmacotherapy Review|Comments Off on Potential Workers Compensation Cost Drivers- Private Label Topicals

Innovating Clinical Intervention

The lack of communication among treating physicians for injured workers has been a known deficit in large loss claims for some time. Professional liability insurance companies have recently issued statements concerning the trend of incomplete patient information, missing tests and poor communication among physicians resulting in lengthier recoveries and costly medical treatment regimens.

Current clinical intervention programs embraced by the industry merely scratch the surface of success as they focus solely on a patient’s medication therapy. The reality is that in […]

By |February 15th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Innovating Clinical Intervention